ACHE and early-onset autosomal dominant Alzheimer disease: Thus, inhibiting AChE can be useful, therapeutically speaking, for several health injuries, such as symptomatic treatment of glaucoma and myasthenia gravis [8,9], as well as the palliative treatment of neurodegenerative diseases, such as some types of sclerosis, depressive disorders, Parkinson’s, Huntington’s, and Alzheimer’s diseases [7,10].